- Home
- SCOR vs ANVS Comparison
SCOR vs ANVS Comparison
Compare SCOR & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCOR
- ANVS
- Stock Information
- Founded
- SCOR 1999
- ANVS 2008
- Country
- SCOR United States
- ANVS United States
- Employees
- SCOR N/A
- ANVS N/A
- Industry
- SCOR Business Services
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- SCOR Consumer Discretionary
- ANVS Health Care
- Exchange
- SCOR Nasdaq
- ANVS Nasdaq
- Market Cap
- SCOR 29.0M
- ANVS 31.2M
- IPO Year
- SCOR 2007
- ANVS 2020
- Fundamental
- Price
- SCOR $6.67
- ANVS $1.48
- Analyst Decision
- SCOR Buy
- ANVS Strong Buy
- Analyst Count
- SCOR 2
- ANVS 5
- Target Price
- SCOR $10.75
- ANVS $37.00
- AVG Volume (30 Days)
- SCOR 18.4K
- ANVS 257.8K
- Earning Date
- SCOR 03-04-2025
- ANVS 05-12-2025
- Dividend Yield
- SCOR N/A
- ANVS N/A
- EPS Growth
- SCOR N/A
- ANVS N/A
- EPS
- SCOR N/A
- ANVS N/A
- Revenue
- SCOR $356,047,000.00
- ANVS N/A
- Revenue This Year
- SCOR $4.01
- ANVS N/A
- Revenue Next Year
- SCOR $4.03
- ANVS N/A
- P/E Ratio
- SCOR N/A
- ANVS N/A
- Revenue Growth
- SCOR N/A
- ANVS N/A
- 52 Week Low
- SCOR $4.89
- ANVS $1.43
- 52 Week High
- SCOR $16.41
- ANVS $20.00
- Technical
- Relative Strength Index (RSI)
- SCOR 50.70
- ANVS 30.83
- Support Level
- SCOR $6.42
- ANVS $1.43
- Resistance Level
- SCOR $7.02
- ANVS $2.07
- Average True Range (ATR)
- SCOR 0.47
- ANVS 0.14
- MACD
- SCOR 0.05
- ANVS 0.04
- Stochastic Oscillator
- SCOR 43.40
- ANVS 7.03
About SCOR comScore Inc.
comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each, across media platforms. The platforms measure include televisions, mobile devices, computers, tablets, CTV devices and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada and Others. It provides solutions for Automotive, Digital Media, Financial Services, FMCG, Pharmaceutical , Retail, Technology and Travel.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.